About Histone deacetylase 1
Histone deacetylase 1 (HDAC1) is a protein
from Homo sapiens identified by UniProt accession
Q13547, 482 residues long.
MolForge cross-references it against 0 known binders and
605 disease associations.
Target properties
| Protein name | Histone deacetylase 1 |
| UniProt accession | Q13547 |
| Gene | HDAC1 |
| Organism | Homo sapiens |
| Length | 482 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (15)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (605)
Diseases linked to this target (Open Targets).
- neoplasm · score 0.57
- multiple myeloma · score 0.57
- unspecified peripheral T-cell lymphoma · score 0.52
- Cutaneous T-cell lymphoma · score 0.52
- T-cell non-Hodgkin lymphoma · score 0.51
- cancer · score 0.50
- graft versus host disease · score 0.39
- primary myelofibrosis · score 0.38
- lymphoma · score 0.37
- Rett syndrome · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13547-F1 | alphafold | PREDICTED | 86.22 | — |
Amino-acid sequence (482 residues)
MAQTQGTRRK VCYYYDGDVG NYYYGQGHPM KPHRIRMTHN LLLNYGLYRK MEIYRPHKAN AEEMTKYHSD DYIKFLRSIR PDNMSEYSKQ MQRFNVGEDC PVFDGLFEFC QLSTGGSVAS AVKLNKQQTD IAVNWAGGLH HAKKSEASGF CYVNDIVLAI LELLKYHQRV LYIDIDIHHG DGVEEAFYTT DRVMTVSFHK YGEYFPGTGD LRDIGAGKGK YYAVNYPLRD GIDDESYEAI FKPVMSKVME MFQPSAVVLQ CGSDSLSGDR LGCFNLTIKG HAKCVEFVKS FNLPMLMLGG GGYTIRNVAR CWTYETAVAL DTEIPNELPY NDYFEYFGPD FKLHISPSNM TNQNTNEYLE KIKQRLFENL RMLPHAPGVQ MQAIPEDAIP EESGDEDEDD PDKRISICSS DKRIACEEEF SDSEEEGEGG RKNSSNFKKA KRVKTEDEKE KDPEEKKEVT EEEKTKEEKP EAKGVKEEVK LA
Explore Histone deacetylase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets